Atara Biotherapeutics Inc (NAS:ATRA)
$ 10.28 -1.35 (-11.61%) Market Cap: 58.33 Mil Enterprise Value: 83.40 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 40/100

Q3 2020 Atara Biotherapeutics Inc Earnings Call Transcript

Nov 09, 2020 / 09:30PM GMT
Release Date Price: $360 (+7.06%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Atara Biotherapeutics Q3 2020 Financial Results Call. (Operator Instructions)

I would now like to hand the conference over to your speaker today, Eric Hyllengren, VP of Investor Relations and Finance of Atara Therapeutics. Thank you. Please go ahead, sir.

Eric Hyllengren
Atara Biotherapeutics, Inc. - Vice President of Investor Relations & Finance

Thank you, operator. Good afternoon, everyone, and welcome to Atara's Third Quarter 2020 Conference Call. On today's call, members from the Atara executive team will provide an update on our financial results and operational progress and also review our upcoming key milestones and objectives.

Earlier today, we issued a press release announcing our third quarter 2020 financial results and operational progress. This press release and an updated investor presentation are available in the Investor and Media section at atarabio.com.

Joining me on today's call are Dr. Pascal Touchon, President and Chief Executive Officer; Dr

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot